MACO Calculation
Maximum Allowable Carryover (MACO) shall be calculated based upon theses three criteria.
Using Health Based Data
Based on Therapeutic Daily Dose (TDD)
Based on LD50
Acceptance Criteria using Health Based Data
CalculateADE (Acceptable Daily Exposure) according to following equation & use the result for the calculation of MACO.
NOAEL × BW
ADE = ———————————
UFc × MF × PK
From ADE value, MACO can be calculated according to;
ADEprevious × MBSnext
MACO = ———————————–
TDDnext
TDDnext
MACO | Maximum Allowable Carryover, Acceptable transferred amount from the previous product into the next product |
ADE | Acceptable daily Exposure (mg/day) |
NOAEL | No observed Adverse Effect Level (mg/kg/day) |
BW | Body Weight of an average Adult (i.e. 70 Kg) |
UFc | Composite Uncertainty Factor , Combination of factors which reflects the inter-individual variability, inter species differences , sub chronic to chronic extrapolation |
MF | Modifying Factor, a factor to address uncertainties not covered by the other factors |
PK | Pharmacokinetics Adjustments |
TDDnext | Std. therapeutic daily dose for the next product (mg/day) |
MBSnext | Minimum Batch size for the next product (s) where MACO can end up (mg) |
Acceptance Criteria Based On Therapeutic Daily Dose
When limited toxicity data is available & therapeutic daily dose is also known, then this method may be used for final product changeover API process.
TDDprevious × MBS next
MACO = —————————————–
SF × TDD next
MACO | Maximum Allowable Carryover, Acceptable transferred amount from the previous product into the next product |
TDDprevious | Std. therapeutic daily dose for the investigated product (mg/day) |
TDDnext | Std. therapeutic daily dose for the next product (mg/day) |
MBSnext | Minimum Batch size for the next product (s) where MACO can end up (mg) |
SF | Safety factor (Normally 1000 is used in calculation based on TDD) |
Acceptance Criteria Based on LD50
In case where no other data is available (e.g. ADE, OEL, TDD etc.) & only LD50 data is available, then MACO can be based upon LD50 Data.
Calculation of NOEL Number (No Observed Effect Level) & this result is used for the MACO calculation.
LD50 × BW
NOEL = ——————————-
2000
MACO can be calculated according to:
NOELprevious × MBSnext
MACO = ——————————————
SFnext × TDDnext
MACO | Maximum Allowable Carryover, Acceptable transferred amount from the previous product into the next product |
NOELprevious | No Observed Effect Level (mg/day) |
LD50 | Lethal Dose 50 in mg/kg Animal. Identification of animal (mouse, Rat etc.) & Route of Administration (IV, oral etc.) is important |
BW | Body Weight of an average Adult (i.e. 70 Kg) |
2000 | Empirical Constant |
TDDnext | Std. therapeutic daily dose for the next product (mg/day) |
MBSnext | Minimum Batch size for the next product (s) where MACO can end up (mg) |
SFnext | Safety factor |
Safety Factor (SF) varies depending on the ROA (Route of Administration)
Generally a factor of 200is employed when manufacturing APIs to be administered in Oral Dosage Forms.
Topical | 10-100 |
Oral Products | 100-1000 |
Parenterals | 1000-10000 |
For any feedback or suggestions write to us at info@pharmastate.com
1- what about cleaning validation at veterinary pharmaceutical manufacturing for cleaning validation implementation ? and the difference between it and the human ?